3,5,4'-trihydroxy-trans-stilbene

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• acne [Insufficient Evidence]
• allergic rhinitis [Possibly Effective]
• beta-thalassemia [Insufficient Evidence]
• cancer prevention [Insufficient Evidence]
• cardiovascular dz prevention [Possibly Ineffective]
• cognitive decline, age-related [Insufficient Evidence]
• cognitive function [Insufficient Evidence]
• cognitive impairment [Insufficient Evidence]
• COPD [Insufficient Evidence]
• COVID-19 [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• diabetic nephropathy [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hypercholesterolemia [Possibly Ineffective]
• metabolic syndrome [Possibly Ineffective]
• menstrual migraine prophylaxis [Insufficient Evidence]
• mitochondrial myopathies [Insufficient Evidence]
• nonalcoholic fatty liver dz [Possibly Ineffective]
• obesity [Possibly Effective]
• osteoarthritis [Insufficient Evidence]
• osteopenia [Insufficient Evidence]
• peritoneal dialysis [Insufficient Evidence]
• periodontitis [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• sciatica [Insufficient Evidence]
• skin aging [Insufficient Evidence]
• ulcerative colitis [Insufficient Evidence]